382 related articles for article (PubMed ID: 24548425)
1. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
Litzlbauer P; Weber K; Mueller RS
Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study.
Carlotti DN; Boulet M; Ducret J; Machicote G; Jasmin P; Rème CA; Albouy M
Vet Dermatol; 2009 Oct; 20(5-6):405-11. PubMed ID: 20178477
[TBL] [Abstract][Full Text] [Related]
3. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
5. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the treatment of canine atopic dermatitis.
Müller MR; Linek M; Löwenstein C; Röthig A; Doucette K; Thorstensen K; Mueller RS
Vet J; 2016 Apr; 210():77-81. PubMed ID: 26975448
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis.
Plant JD; Gortel K; Kovalik M; Polissar NL; Neradilek MB
Vet Dermatol; 2012 Dec; 23(6):515-e103. PubMed ID: 23140318
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.
Olivry T; Saridomichelakis M; Nuttall T; Bensignor E; Griffin CE; Hill PB;
Vet Dermatol; 2014 Apr; 25(2):77-85, e25. PubMed ID: 24461108
[TBL] [Abstract][Full Text] [Related]
10. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
[TBL] [Abstract][Full Text] [Related]
11. The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis.
Blaskovic M; Rosenkrantz W; Neuber A; Sauter-Louis C; Mueller RS
Vet J; 2014 Jan; 199(1):39-43. PubMed ID: 24355814
[TBL] [Abstract][Full Text] [Related]
12. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
Mueller RS; Veir J; Fieseler KV; Dow SW
Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
[TBL] [Abstract][Full Text] [Related]
13. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E supplementation in canine atopic dermatitis: improvement of clinical signs and effects on oxidative stress markers.
Plevnik Kapun A; Salobir J; Levart A; Tavčar Kalcher G; Nemec Svete A; Kotnik T
Vet Rec; 2014 Dec; 175(22):560. PubMed ID: 25205675
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
Marsella R
Vet Dermatol; 2010 Dec; 21(6):566-71. PubMed ID: 20492623
[TBL] [Abstract][Full Text] [Related]
17. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
19. Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.
Fujimura M; Ishimaru H
Pol J Vet Sci; 2016; 19(1):3-6. PubMed ID: 27096781
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of neural therapy for the treatment of atopic dermatitis in dogs.
Bravo-Monsalvo A; Vázquez-Chagoyán JC; Gutiérrez L; Sumano H
Acta Vet Hung; 2008 Dec; 56(4):459-69. PubMed ID: 19149101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
